# HVNI vs NIPPV in Type 2 Respiratory Failure

> **NCT07065656** · NA · NOT_YET_RECRUITING · sponsor: **National University Hospital, Singapore** · enrollment: 84 (estimated)

## Conditions studied

- Respiratory Failure
- Hypoxia
- Hypercapnia

## Interventions

- **DEVICE:** Vapotherm high velocity therapy (HVT) 2.0 (Vapotherm, Inc, Exeter, NH)
- **DEVICE:** Respironics Vision V60

## Key facts

- **NCT ID:** NCT07065656
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07065656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07065656, "HVNI vs NIPPV in Type 2 Respiratory Failure". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07065656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*